Expression of CD40 and CD40L in gastric cancer tissue and its clinical significance

International Journal of Molecular Sciences

Volumn 10, Issue 9, 2009, Pages 3900-3917

  Li, Rui ^a   Chen, Wei Chang ^a   Pang, Xue Qin ^a   Hua, Chen ^a   Li, Ling ^a   Zhang, Xue Guang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; CD138; CD40; CD40L; Gastric cancer

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; SYNDECAN 1;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CANCER IMMUNOLOGY; CANCER INVASION; CANCER SIZE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; STOMACH CANCER; STOMACH CARCINOMA; VENOUS BLOOD;

APOPTOSIS; CD138; CD40; CD40L; GASTRIC CANCER;

ADULT; AGED; ANTIGENS, CD40; CASE-CONTROL STUDIES; CD40 LIGAND; FEMALE; GELSOLIN; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; SYNDECAN-1; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 70350069890     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10093900     Document Type: Article

References (18)

1. Hakim, F.T.; Flomerfelt, F.A.; Boyiadzis, M.; Gress, R.E. Aging, immunity and cancer. Curr. Opin. Immunol. 2004, 16, 151-156.
2. Chakrabarti, S.; Rizvi, M.; Pathak, D.; Kirber, M.T.; Freedman, J.E. Hypoxia influences CD40- CD40L mediated inflammation in endothelial and monocytic cells. Immunol. Lett. 2009, 122, 170-184.
3. Chen, D.; Adenekan, B.; Chen, L.; Darracott Vaughan, E.; Gerald, W.; Feng, Z.; Knudsen, B.S. Syndecan-1 expression in locally invasive and metastatic prostate cancer. Urology 2004, 63, 402-407.
4. Gay, F.; Estornes, Y.; Saurin, J.-C.; Joly-Pharaboz, M.-O.; Friederich, E.; Scoazec, J.-Y.; Abello, J. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma. Human Pathol. 2008, 39, 1420-1430.
5. Soong, R.; Robbins, P.D.; Dix, B.R.; Grieu, F.; Lim, B.; Knowles, S.; Williams, K.E.; Turbett, G.R.; House, A.K.; Iacopetta, B.J. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Human Pathol. 1996, 27, 1050-1055.
6. Wu, Y.G.; Wang, L.; He, X.Z.; Xu, H.Y.; Zhou, L.C.; Zhao, F.; Zhang, Y.Y. Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo. Cell Immunol. 2008, 253, 102-109.
7. Grammer, A.C.; Lipsky, P.E. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms. Adv. Immunol. 2000, 76, 61-178.
8. van Kooten, C.; Banchereau, J. CD40-CD40 ligand. J. Leukocyte Biol. 2000, 67, 2-17.
9. Eeva, J.; Ropponen, A.; Nuutinen, U.; Eeva, S.-T.; Mättö, M.; Eray, M.; Pelkonen, J. The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP. Mol. Immunol. 2007, 44, 1230-1237. (Pubitemid 44415970)
10. Hayward, A.R.; Levy, J.; Facchetti, F.; Notarangelo, L.; Ochs, H.D.; Etzioni, A.; Bonnefoy, J.Y.; Cosyns, M.; Weinberg, A. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 1997, 158, 977-983.
11. Aukrust, P.; Muller, F.; Ueland, T.; Berget, T.; Aaser, E.; Brunsvig, A.; Solum, N.O.; Forfang, K.; Froland, S.S.; Gullestad, L. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation 1999, 100, 614-620.
12. Tao, Y.F.; Nomura, M.; Kitabatake, N.; Tani, F. Mouse CD40-transfected cell lines cannot exhibit the binding and RANTES-stimulating activity of exogenous heat shock protein 70. Mol. Immunol. 2007, 44, 1262-1273. (Pubitemid 44415967)
13. Li, R.; Chen, W.-C.; Wang, W.-P.; Tian, W.-Y.; Zhang, X.-G. Optimization of extraction technology of Astragalus polysaccharides by response surface methodology and its effect on CD40. Carbohyd. Polym. 2009, 78, 784-788.
14. Li, R.; Chen, W.-C.; Wang, W.-P.; Tian, W.-Y.; Zhang, X.-G. Extraction, characterization of Astragalus polysaccharides and its immune modulating activities in rats with gastric cancer. Carbohyd. Polym. 2009, 78, 738-742.
15. Oki, E.; Maehara, Y.; Tokunaga, E.; Kakeji, Y.; Sugimachi, K. Reduced expression of p33ING1 and the relationship with p53 expression in human gastric cancer. Cancer Lett. 1999, 147, 157-162. (Pubitemid 29087907)
16. Szkaradkiewicz, A.; Majewski, W.; Wal, M.; Czyżak, M.; Majewski, P.; Bierła, J.; Kuch, A. Epstein-Barr virus (EBV) infection and p53 protein expression in gastric carcinoma. Virus Res. 2006, 118, 115-119.
17. Kim, H.-S.; Choi, Y.J.; Baik, S.K.; Lee, D.K.; Kwon, S.O.; Oh, E.-S. mRNA expression of syndecan-2 in human colon cancer and polyp tissue: A pilot study. Gastroenterology 2003, 124, A607.
18. Briggs, C.D.; Neal, C.P.; Mann, C.D.; Steward, W.P.; Manson, M.M.; Berry, D.P. Prognostic molecular markers in cholangiocarcinoma: A systematic review. Eur. J. Cancer 2009, 45, 33-47.